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Abstract
Introduction: Neurological symptoms after percutaneous coronary intervention can have grave
implications. The symptoms may result from relatively benign conditions like migraine to potentially
life-threatening conditions such as intracranial bleeding.
Case presentation: We describe a case of a 57-year-old woman who developed significant
neurological symptoms following percutaneous coronary intervention. An early 'unenhanced'
computed tomography scan of the brain was reported as a possible 'subdural haematoma'. The
symptoms reversed within hours and the computed tomography scan was normal 24 hours later.
The diagnosis and its possible mechanism are discussed.
Conclusion: Definitive diagnosis in such a case can only be obtained from the radiological features
and thus a detailed study is essential.
Introduction
Neurological symptoms after percutaneous coronary
intervention (PCI) can have grave implications. The
symptoms may result from relatively benign conditions
like migraine to potentially life-threatening conditions
such as intracranial bleeding. Confirmation of the diagno-
sis is essential as inappropriate use of antiplatelet thera-
pies could potentially lead to major adverse events.
Radiology may be the only investigative modality availa-
ble for confirmation of diagnosis. This case highlights the
difficulties in diagnosis.
Case presentation
A 57-year-old woman underwent PCI within 24 hours of
an anterior ST-elevation myocardial infarction for which
she was thrombolysed with tenecteplase. She had aspirin
300 mg and clopidogrel 600 mg loading before, 70 U/kg
of heparin and a weight-adjusted bolus of abciximab dur-
ing, and an abciximab infusion after the procedure. Two
overlapped sirolimus-eluting stents were deployed in the
mid left anterior descending artery, a procedure that went
uneventfully. She received 350 ml of iohexol. Two hours
after the procedure she complained of severe occipital
headache, photophobia and shimmering lights in her vis-
ual field. She rapidly developed confusion, slurred speech,
motor dysphasia and paraesthetic symptoms in her left
arm. Neurological examination was otherwise normal
with no signs of meningeal irritation or raised intracranial
pressure. She was known to suffer from migraine but
denied ever having experienced any neurological symp-
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'Unenhanced' computed tomography scan of a brain 4 hours (A) and 24 hours (B) after percutaneous coronary interventionFigure 1
'Unenhanced' computed tomography scan of a brain 4 hours (A) and 24 hours (B) after percutaneous coronary 
intervention. A) Scan shows high attenuation over the tentorium extending along the falx, over the cerebellar convexities 
and within the dural sinuses (vein of Galen, straight and transverse sinuses) and smaller veins overlying the tentorium (arrows) 
with no brain parenchymal or intraventricular enhancement. B) Normal brain scan.
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bleeding.
The abciximab was stopped. A computed tomography
(CT) scan of the brain 4 hours after the procedure (Figure
1A) was reported by the on-call staff radiologist as a pos-
sible subdural haemorrhage. The neurosurgeons sug-
gested conservative treatment in view of the recent use of
potent antiplatelet agents. The patient's symptoms
resolved completely within 6 hours. A CT scan 24 hours
later (Figure 1B) was normal and was reported by the neu-
roradiologist the next day as a normal scan with contrast.
We believe that classical migraine was the cause of the
neurological symptoms.
Discussion
Neurological symptoms following the use of potent
antiplatelet agents and anticoagulants during PCI always
raise the frightening possibility of a major intracranial
haemorrhage. The purpose of this report is to emphasise
that the importance of excluding intracranial haemor-
rhage as a cause for the neurological symptoms after PCI
far exceeds that after angiography, as inappropriate with-
drawal or continuation of the antiplatelet agents could
both result in serious consequences for the patient. The
fact that the appearance of the CT scan raised a suspicion
of an intracranial bleed makes the differentiation all the
more important as an opinion of a specialist neuroradiol-
ogist may not be available out-of-hours. And, radiology is
possibly the only investigation available as lumbar punc-
ture for cerebrospinal fluid (CSF) xanthochromia is con-
traindicated in these patients. The anatomical location of
any bleeding is less important.
In the clinical scenario presented, intracranial bleeding
needed to be firmly differentiated from parenchymal
extravasation of iodinated contrast and a 'normal'
enhanced scan. Intracranial haemorrhage occurs in 0.06%
to 0.14% of patients treated with GpIIbIIIa inhibitors [1].
Extravasation of contrast medium within the brain paren-
chyma and the CSF spaces may occur with intra-arterial
administration of contrast medium. It has been reported
after coronary, peripheral, abdominal, cerebral and spinal
angiography. It usually manifests as reversible neurodefi-
cit such as cortical blindness, global or partial amnesia,
seizures, hemiplegia or unconsciousness. Direct toxicity
related to certain critical groups on the contrast media
molecules [2] and vasospasm [3] may both play a role in
the pathogenesis. It is less common with a nonionic con-
trast medium and the volume of contrast needed to
induce such changes is unknown, as the amount adminis-
tered varies widely in published reports. Restricting the
amount reduces [4], and renal insufficiency increases [5],
the risk of extravasation.
The radiological features of extravasated contrast medium
include diffuse hyper-attenuation of the cortical paren-
chyma without evident relationship to a particular vascu-
lar territory. The attenuation values are higher for
extravasated contrast than for blood [6]. Contrast media
within the subarachnoid space is rapidly absorbed but
≤50% of subarachnoid blood is removed within 24 hours
[7]. The mechanisms by which the blood-brain-barrier
(BBB) could be breached include transient osmotic dis-
ruption due to the contrast [8], severe hypertension [9]
and a cerebral ischaemic event secondary to atheroembo-
lism during coronary intervention. A sudden severe rise in
blood pressure, exceeding the autoregulatory capacity of
the cerebral vessels, produces regions of vasodilatation
and vasoconstriction with a breakdown of the BBB and
focal transudation of fluid [9].
In our patient, the amount of contrast administered was
not excessive and her blood pressure remained normal
throughout the procedure. The pattern of enhancement
matched neither an intracranial bleed nor parenchymal
extravasation of contrast. The contrast disappeared rap-
idly. The enhancement patterns did not follow that of inf-
arction either, that is, they occurred very early, within 4
hours, were extra-parenchymal and did not affect one sin-
gle vascular territory [10,11]. All these features excluded
an intracranial event as a cause for the transient neurodef-
icits and confirmed classical migraine as the likely etiol-
ogy. Cerebral vasospasm [3] may have contributed.
Conclusion
This case highlights a difficult diagnostic dilemma that
has profound implications for patient management.
Despite the increased likelihood of an intracranial bleed
in this case, the diagnosis needed to be firmly excluded. A
diagnosis based on the radiological findings is the only
available option and thus should be reached only after
careful consideration among the treating cardiologists
and radiologists.
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